Ribonucleic acid, also called RNA, is a molecule present in all living cells. It plays a critical role in transmitting ...

Eli Lilly is further expanding its RNA medicine strategy by tapping South Korea’s Rznomics for a $1.3 billion biobucks deal ...

In a new study published in Cell Reports, researchers at the University of Freiburg reveal how a disordered protein segment ...

Lilly will use Rznomics’ proprietary ribozyme technology to develop RNA editing therapies for congenital hearing loss.

The majority of RNAs in each of our cells don't code for any of the thousands of proteins that make up our bodies. Instead, ...

AIRNA today announced preclinical proof-of-concept data supporting its best-in-class RNA editing strategy for alpha-1 ...

Dr. Anastasia Khvorova for her pioneering work in the field of RNA-based therapies. At 2.5 million euros, the prize is one of the most prestigious and generously endowed of any medical research prize ...

Yale researchers have now developed a method to map and measure the structure of RNA as it develops, an advance that may help ...

The siRNA technology has has the potential to enable sustained and precise messenger RNA silencing, regulating the expression ...

Scientists at the McGovern Institute and the Broad Institute of MIT and Harvard have reengineered a compact RNA-guided enzyme ...

The interaction between RNA-binding proteins (RBPs) and circular RNAs (circRNAs) has emerged as a key area of interest in ...